Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 87 days for 2021).
- 2024not filed
- 202305/08/2024
- 202212/09/2023
- 202110/10/2022
- 202014/10/2021
- 201914/10/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Public procurement
8 tenders recorded as contractor: 7 national ($65,562) and 1 EU ($1,839).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 15, 2024 | Supply of police technical equipment for the needs of police units in the Pomeranian police region | $1,839$1,839 | Komenda Wojewódzka Policji w Gdańsku | |
| Sep 18, 2023 | SZPiFP-69-23 Supply of supplementary tests for the Narko-II kit for Police units in Kujawsko-Pomorskie Voivodeship. | $16,023$16,023 | Komenda Wojewódzka Policji w Bydgoszczy | |
| Jul 14, 2023 | Supply of field drug and psychotropic substance tests and forensic materials for the police units of the Pomeranian garrison | $10,409$10,409 | Komenda Wojewódzka Policji w Gdańsku |
Trademarks
Transfarm currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1999.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| TRANSFARM Sp. z o.o. | Z.211733 | 1, 3, 5, 9, 10, 16, 35, 37, 42 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| TRANSFARM Sp. z o.o. | – |
Authorized Representatives
Manner of representation
To represent the company (to make declarations on behalf of the company), the following are authorised: 1. the President of the Management Board acting independently; 2. each Vice-President acting independently; 3. two members of the management board other than the President of the Management Board or the Vice-President acting jointly; 4. a member of the management board other than the President of the Management Board or the Vice-President acting jointly with a commercial proxy, where that commercial proxy has been granted joint commercial procuration; 5. a commercial proxy acting independently, where that commercial proxy has been granted sole (separate) commercial procuration; 6. two commercial proxies acting jointly, where they have been granted joint commercial procuration.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jarosław Kazimierz Golendaage 56 | 100 | $27,012.43 | 33.3333% |
Jerzy Bogusław Mrygońage 52 | 50 | $13,506.21 | 16.6667% |
Tomasz Świerkage 48 | 100 | $27,012.43 | 33.3333% |
Ewa Szafrańskaage 63 | 50 | $13,506.21 | 16.6667% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 1994-05-05 to 2025-08-08.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
6 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Feb 19, 2026 | Discontinued enforcement proceedings | Closed | |
| Feb 19, 2026 | Discontinued enforcement proceedings | Closed | |
| Feb 19, 2026 | Discontinued enforcement proceedings | Closed | |
| Feb 19, 2026 | Discontinued enforcement proceedings | Closed | |
| Feb 19, 2026 | Discontinued enforcement proceedings | Closed |
Public aid
5 public aid cases recorded, with a total value of $4,039.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Oct 16, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | URZĄD SKARBOWY WARSZAWA-URSYNÓW | |
| Mar 26, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | URZĄD SKARBOWY WARSZAWA-URSYNÓW |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | ||
| Alpen Pharma Polskasp. z o.o. | $1,465,675.63 | alpenpharma.pl | ||
| Dermaprofilsp. z o.o. | $1,431,262.08 | dermaprofil.pl | ||
| Atradis Polskasp. z o.o. | $1,284,064.17 | atradis.pl | ||
| Sepharmasp. z o.o. | $1,263,307.80 | sepharma.pl | ||
| Aptissen Polskasp. z o.o. | $1,246,592.59 | aptissen.com | ||
| Eickemeyer - Veterinary Technology for Lifesp. z o.o. | $1,238,702.38 | eickemeyer.pl | ||
| Mana Medicalsp. z o.o. | $1,210,831.22 | manamedical.pl | ||
| Octapharma Polandsp. z o.o. | $1,191,691.61 | octapharma.com | ||
| JJH Medical Bartosz Hiczkiewiczsp. k. | $1,076,466.09 | jjhmedical.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-29 | Address change (Ul. Puławska 370, 02-819, Warszawa → Warszawa) | |
| 2015-07-17 | Address change (Kanarkowa 20b, 02-818, Warszawa → Ul. Puławska 370, 02-819, Warszawa) | |
| 2012-05-29 | Address change (Zaciszna 25a, 02-912, Warszawa → Kanarkowa 20b, 02-818, Warszawa) | |
| 2008-08-27 | Share capital increase (96,000.00 PLN → 300,000.00 PLN) | |
| 2001-06-11 | Entered in the register |
FAQ
Last updated: 2026-10-29